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Background: Obesity is known to be associated with inflammation, oxidative stress and a resulting reduction in
sperm DNA integrity. Importantly, obesity is also reported to be associated with an increase in intestinal
permeability with the passage of intestinal bacteria into the circulation (metabolic endotoxemia) that triggers a
systemic state of inflammation and resultant oxidative stress. Therefore, we hypothesised that this obesity related
increase in intestinal permeability and resultant metabolic endotoxemia (ME) may activate inflammation within the
male reproductive tract, leading to increased reactive oxygen species production, sperm oxidative stress and a
decline in DNA integrity.
Results: Our pilot study of 37 infertile men confirmed a significant positive correlation between body mass index
(BMI), increased intestinal permeability (serum zonulin), metabolic endotoxaemia (LBP), sperm DNA oxidative
damage (seminal 8 OhDG) and increasing levels of sperm DNA fragmentation (Halosperm). Metabolic endotoxemia
was positively correlated with increasing levels of sperm DNA oxidative damage with this relationship remaining
significant, even after adjustment for relevant confounders such as age, BMI and days of abstinence. These
observations suggest that metabolic endotoxemia and its associated oxidative stress may be a key driver of sperm
DNA damage in obese men.
Conclusion: This study confirms a link between obesity, increasing intestinal permeability and endotoxin exposure,
and oxidative mediated sperm DNA damage. This warrants further investigation to fully understand the effect of
metabolic endotoxemia on male reproductive function which could result in the new therapies to improve male
fertility potential.
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Infertility is a significant public health problem affecting
15% of couples worldwide [1]. Male factors are involved
in 50% of cases, with paternal obesity being suggested as
an underlying cause for both a reduction in sperm count
[2–5] and an increase in sperm DNA damage [6], as well
as epigenetic changes with possible long term health
consequences for the child if conception were to occur
[6]. Furthermore, despite the use of assisted reproductive
treatment, paternal obesity has been linked in some
studies with reduced live birth rates following In Vitro© The Author(s). 2019 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/ze
* Correspondence: karma.pearce@unisa.edu.au
1School of Pharmacy and Medical Sciences, Division of Health Sciences,
University of South Australia, Adelaide, South Australia 5001, Australia
Full list of author information is available at the end of the articleFertilisation (IVF) treatment, even after controlling for
maternal weight [7, 8]. This may be of particular import-
ance as the proportion of overweight or obese males in
reproductive age men in the developed world now ex-
ceeds 50% and appears to be increasing over time [9].
A recent review by Mushtaq et al. [10] has reported
that obese men are more likely to have reduced semen
volume, total sperm number and total sperm count
resulting in reduced fertility and fecundity. Furthermore,
a recent meta-analysis of 52 animal studies examining
the impact of a high-fat obesogenic diet also reported
that increased adiposity was associated with reduced
semen quality, reduced fertilization and a decline in nat-
ural fertility [11]. Kahn et al. [12] report that adipose
tissue-derived factors, such as adipokines and leptinle is distributed under the terms of the Creative Commons Attribution 4.0
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spectively. Increased systemic inflammation results in in-
creased reactive oxygen species (ROS) and in turn sperm
DNA fragmentation. Furthermore, increased testicular
temperature and inactivity also impairs spermatogenesis.
However, the total effect of obesity on hormone levels,
semen parameters and sperm DNA integrity, is variable
suggesting multiple mechanisms may be in play [12].
It is well recognised that human observational studies
can only draw correlations between BMI and male re-
productive function which may not be directly causa-
tional in nature. Impaired reproductive function in the
obese male is likely to be directly related to both his ex-
cessive adiposity, but also other potential confounding
lifestyle factors such as a diet high in processed foods or
deficient in key micro-nutrients or a lack of exercise.
One possible link between obesity and reduced fertility
rates that has yet to be explored is metabolic endotoxe-
mia (ME). Here the ingestion of large amounts of food,
especially fatty food, has been shown to produce an in-
crease in intestinal permeability [13, 14] and the passage
of gut bacteria from within the intestinal lumen into the
systemic circulation. These predominantly gram negative
gut bacteria contain the potent immune stimulant endo-
toxin (LPS) on their cell wall which activates a protective
systemic inflammatory response to help clear the bacter-
ial intrusion. Recent research from our group has shown
that ME is positively correlated with inflammation
(serum C-reactive protein, IL-6) in obese men, and this
inflammatory response is associated with impaired tes-
ticular function signified by reduced testosterone pro-
duction [15, 16]. However, to date the potential link
between obesity, intestinal permeability, metabolic endo-
toxemia, and impaired sperm quality has yet to be
investigated.
Our hypothesis that ME may impair spermatogenesis
is scientifically plausibility and outlined in detail our
GELDING theory (Gut Endotoxin Leading Decline IN
Gonadal function) hypothesis paper [17]. Firstly, ME in-
creases systemic inflammation in humans [18] with in-
flammation being characterised by elevated ROS
(reactive oxygen species) production by activated leuko-
cytes that are known to impair sperm function [19],
while also initiating a positive feedback inflammatory
loop that further potentiates inflammation and oxidative
stress [18, 20–25]. While there is a paucity of evidence
linking ME with reduced semen quality, there is good
evidence linking leaky gut with ME and systemic inflam-
mation [26], plus there is strong evidence linking inflam-
mation with reduced semen quality [27]. Secondly, LPS
(the primary endotoxin molecule) is known to directly
impair sperm function. Healthy sperm cultured in the
presence of LPS exhibit a decrease in motility and an in-
creased production of potentially damaging ROS [22].Furthermore, in vivo administration of endotoxin to
healthy animals has been shown to initiate seminal oxi-
dative stress [28] and impair sperm production and fer-
tility [28–30]. The presence of endotoxin receptors (TLR
4) on sperm membranes, and their ability to initiate an
increase in their IL-6 production in response to LPS
[31], suggests that sperm are capable of recognising bac-
terial endotoxin [32]. Furthermore, exposure of a
leukocyte -free sperm suspension to LPS in vitro has
been reported to directly initiate apoptosis [32], a known
trigger for sperm DNA damage. As such, these studies
suggest that endotoxin exposure may alter sperm func-
tion both directly and indirectly via activation of a
leukocyte ROS response.
The aim of this study was to investigate the effect of
metabolic endotoxemia (LPS) on sperm production and
quality. We hypothesise that increasing endotoxin levels
will activate inflammation within the male reproductive
tract, leading to increased leukocyte activity and sperm




Between February 2017 and June 2017, 45 men aged 18
to 50 years were recruited from a private fertility clinic
in South Australia (Repromed) through advertisements.
Inclusion criteria was being in an infertile relationship
and exclusion criteria were documented inflammatory or
infectious disease, primary hypogonadism (Klinefelters
Syndrome, cryptorchidism or testicular injury), the
consumption of immunosuppressive medication (e.g.,
nonsteroidal anti-inflammatory drugs (NSAID), cortico-
steroids or fish oil), supplements that may alter intestinal
function (e.g., probiotics, antibiotics in the last 1 month)
or any male hormonal therapy (i.e. aromatase inhibitors,
clomiphene citrate, human chorionic gonadotropin
(hCG) or testosterone). All men were screened for
sub-clinical genital tract infection using seminal plasma
elastase [33]. This study was approved by the University
of South Australia Ethics Committee (approval number
0000036399), with informed written consent being ob-
tained from all participants.
Study protocol
Unfasted blood and semen samples were provided by
all participants between 7:30 am and 11:00 am on the
day of testing. Participants were also required to
produce a semen sample via masturbation after main-
taining an abstinence period of 2–7 days. The semen
was analysed within 2 h of collection. Anthropometric
measures were also collected; height was measured
to the nearest 1 cm (Seca, 216, Germany). Weight
and body fat percentage were measured using a
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Corporation of America Inc.). Waist circumference
was measured from the midpoint of the distance be-
tween the top of the iliac crest and the twelfth rib
and measured to the nearest 1 cm. Body mass index
(BMI) was calculated using the equation body weight
(kg)/height (m2) and classified using the WHO ranges;
underweight (< 18.50 kg/m2), normal weight (18.50 kg/m2
– 24.99 kg/m2), overweight (25.00 kg/m2 – 29.99 kg/m2)
and obese (> 30 kg/m2) [34].
Endotoxin analysis
Metabolic endotoxemia was quantified indirectly by
Lipopolysaccaride Binding Protein (LBP) analysis of
plasma in duplicate using a dilution of 1:1000 according
to the manufacturer’s guidelines (Hycult, Uden,
Netherlands), and as previously reported by our group
[15, 16]. The minimum detectable concentration of LBP
being 4.4 ng/mL. The assay protocol reports no
cross-reactivity with non-human LBP.
Intestinal permeability: Zonulin
Intestinal permeability was investigated by measuring
levels of zonulin in plasma in duplicate using a hu-
man zonulin ELISA kit according to the manufac-
turer’s instructions (Crux, Melbourne; Cusabio, USA).
This assay reported an inter-assay coefficient of
variation of 3% and reference range of 0.156 ng/mL-
40 ng/mL.
Seminal plasma inflammatory activity markers
Elastase, a marker of neutrophil activity within the male
reproductive tract was measured in frozen (−80C) and
then thawed seminal plasma in duplicate using the Hu-
man Elastase 2 Neutrophil ELISA kit according to the
manufacturer’s instructions (Crux, Melbourne). This test
had a coefficient of variation of 2% with a reference
range of 1.56 ng/mL– 400 ng/mL, with levels exceeding
290 ng/ml suggestive of genito-urinary tract infection/
inflammation [13].
Seminal oxidative stress: 8-hydroxy-2′-deoxyguanosine (8-
OHdG)
The inflammatory marker 8-hydroxy-2′-deoxyguanosine
(8OHdG) was also measured in in frozen (−80C) and
then thawed seminal plasma in duplicate using a human
8OHdG ELISA kit according to the manufacturer’s in-
structions (Crux, Melbourne). This assay had a reference
range of 2.0 - 800 ng/mL.
Semen analysis
Total sperm concentration was calculated according to
WHO V guidelines [35]. DNA fragmentation was also
assessed in duplicate by the same analyst according tothe manufacturer’s guidelines (Halosperm G2, Halotech,
Spain). Briefly, total sperm motility was calculated after
liquefaction. Two hundred spermatozoa were counted
and defined as motile or immotile depending on move-
ment classified by WHO [35]. The numbers were re-
corded and percentage total motility was determined. A
morphology slide was prepared, fixed, stained and scored
to determine the sperm morphology according to strict
WHO specifications, with the percentage of good mor-
phological spermatozoa in 400 sperm reported [35]. The
percentage of fragmented DNA was determined after as-
sessment of 400 individual spermatozoa. Within our la-
boratory high quality sperm samples (e.g.sperm donors)
generally have Halosperm DNA damage levels of less
than 5%, with patient results above 20% generally being
considered abnormal.
Hormone analysis
Serum was analysed for testosterone, estradiol, follicle
stimulating hormone (FSH) and luteinising hormone
(LH) using an automated chemiluminescence immuno-
assay (Cobas 6000 e 601, Roche Diagnostics, USA), with
the detectable ranges for each hormone being 18.4–
110.10 pmol/L, 0.087–52.0 nmol/L, 0.1-200mIU/mL and
0.2-100mIU/mL respectively.
Statistical analysis
Statistical analyses were conducted using Statistical
Product and Service Solution Software, version 23 (SPSS
Inc., Chicago, IL, USA). Data was expressed as mean (+
standard deviation) when normally distributed, or as a
median (inter-quartile range) when not normally distrib-
uted according to the Shapiro-Wilk test. Correlations
were assessed using the Pearson’s method, with log
transformation of non-normally distributed data prior to
statistical analysis. Where appropriate, adjustments were
made for age, smoking status and measures of adiposity.
Results
Participant characteristics
While 43 men were assessed for eligibility; 5 were ex-
cluded for taking fish oil and 1 for taking antibiotics
within the last month. Of the remaining 37 men avail-
able for analysis, their average age was 36.9 ± 5.2 years
and BMI was 30.2 ± 4.7 kg/m2. Only 10.8% of the cohort
were of normal BMI, with the remainder being either
overweight (BMI 25–29.9, 45.9%) or obese (BMI > 30,
43,2%) [34]. The male fertility potential of the majority
of participants was unknown at the time of recruitment.
After full assessment the causes of infertility were pure
male factor 14 subjects (37.8%), pure female factor 10
subjects (27%), combined male and female factor 6 sub-
jects (16.2%) and unknown cause 7 subjects (19%). The
cohort demographic data is outlined in Table 1.
Table 1 Participant demographic, endocrine and inflammatory
characteristics
Variable Mean + SD (median, IQR) Range
Age (years) 36.9 ± 5.2 28.0–46.0
BMI (kg/m2) 30.2 ± 4.7 23.3–41.6
Waist circumference (cm) 97.0 (67.0–131.5) 87.0–127.0
% body fat 28.4 ± 8.4 16.1–45.6
Sperm count (million/mL) 54.5 ± 5.5 1.8–204.0
Sperm motility (%) 57.0 (49.0–65.0) 46.0–81.0
Normal sperm morphology (%) 1.1 ± 1.6 3.5–11.0
Sperm DNA fragmentation (%) 14.0 ± 2.4 8.5–33
Seminal elastase (ng/mL) 29.8 ± 12.2 3.0–67.1
Seminal 8OHdG (ng/mL) 7.5 ± 3.1 0.9–90.8
Total testosterone (nmol/L) 15.3 ± 6.2 4.5–27.1
LH (IU/L) 5.1 ± 1.1 2.5–10.2
FSH (IU/L) 3.5 (1.7–5.2) 1.6–13.9
Estradiol (pmo/L) 77.2 ± 8.2 18.4–98.5
Data expressed as mean + SD or median (Inter-Quartile Range), depending on
their normal distribution status
LBP Lipopolysaccharide Binding Protein. (n = 37)
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As anticipated, there was a significant positive correl-
ation between the intestinal permeability marker serum
zonulin and BMI (R = 0.331, p = 0.045). There was also a
significant positive relationship between zonulin and the
endotoxemia marker LBP (R = 0.374, p = 0.025). How-
ever, no significant relationships were apparent between
serum zonulin and markers of male reproductive tract
inflammation (elastase), sperm oxidative damage (8
OHdG) or any sperm quality marker.a  
R=0.468
P=0.010
Fig. 1 The relationship between BMI and both and sperm DNA damage an
between body mass index (BMI) and sperm DNA damage. b Relationship b
8-hydroxy-2′-deoxyguanosine (8OHdG)Endotoxemia (LBP) was positively correlated with BMI
and % body fat (R = 0.375, p = 0.024; R = 0.407, p = 0.017
respectively), (Fig. 1). There were no significant relation-
ships between LBP and total sperm count (R = 0.266, p
= 0.148), sperm morphology (R = 0.305, p = − 0.102) or
sperm motility (R = 0.107, p = 0.208), with these relation-
ships remaining unaltered after controlling for age, per-
centage body fat and the number of days abstinence. A
key finding was the positive relationship between sperm
DNA fragmentation and metabolic endotoxemia (LBP;
R = 0.460, p = 0.021), with this relationship being main-
tained even after adjustment for age and percentage
body fat (r = 0.462, p = 0.023) (Fig. 1). This positive cor-
relation was also maintained after further adjusting for
days abstinence, a key determinant of sperm DNA integ-
rity (R = 0.434, p = 0.027) [36].Sperm DNA quality markers
Sperm DNA fragmentation was also positively associated
with all measures of adiposity (BMI; R = 0.468, p = 0.010,
% body fat; R = 0.512, p = 0.006, waist circumference; R
= 0.460, p = 0.012) (Fig. 1).
As expected, seminal 8OHdG, a marker of seminal
oxidative stress was significantly positively correlated
with BMI (R = 0.418, p = 0.021). A negative relationship
between sperm motility and seminal 8OHdG (following
adjustment for sperm number) was also observed (R
= -0.624, p = 0.002). Conversely, a significant positive re-
lationship was observed between endotoxin exposure
(LBP) and seminal 8OHdG (R = 0.440, p = 0.016), con-
firming a link between endotoxemia and oxidative stress
(Fig. 2). Seminal 8OHdG was also strongly correlated
with BMI (R = 0.418, p = 0.021) (Fig. 2).b 
R=0.418
P=0.021
d seminal 8-hydroxy-2′-deoxyguanosine (8OHdG). a Relationship
etween body mass index (BMI) and seminal
Fig. 2 The effect of LBP on both seminal DNA fragmentation and seminal 8-hydroxy-2′-deoxyguanosine (8OHdG). a Relationship between an
indirect measure of endotoxin (LBP) and seminal DNA fragmentation. b Relationship between an indirect measure of endotoxin (LBP) and
seminal 8-hydroxy-2′-deoxyguanosine (8OHdG)
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As expected, serum testosterone was inversely correlated
with BMI, body fat percentage and waist circumference,
with strong effect sizes for each (R = -0.623, p < 0.001; R
= -0.643, p < 0.001; R = -0.677, p < 0.001 respectively). All
correlations were maintained when adjusted for age (p <
0.001 for all variables) (Table 2). Furthermore, FSH was
inversely correlated with BMI (R = − 0.373, p = 0.011).
Serum LH and estrogen were not correlated with any
measures of adiposity (p > 0.05 for all).Table 2 Correlation matrix
Statistical analysis using the Pearson correlation test. All values represent correlation
indicated in bold type
LH Luteinising hormone, FSH follicle stimulating hormone, LPS LipopolysaccarideDiscussion
Our research team has recently demonstrated that ex-
perimental administration of low-dose endotoxin (0.8 ng
Escherichia coli O113:H10/kg body weight) results in a
rapid decline in testosterone production in healthy re-
productive age men [16], thereby directly confirming the
capacity of bacterial endotoxin to impair testicular func-
tion. However, the results of this pilot study are the first
to identify a significant positive correlation between bac-
terial endotoxin exposure (LBP) and impaired spermcoefficient value (r), with those reaching statistical significance (p < 0.05)
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cant even after adjusting for relevant confounders such
as age, BMI and duration of abstinence. The results of
our study give some insight into a potential mechanism
for the increased levels of sperm DNA damage seen in
obese men. In summary we believe that obesity and its
associated poor diet causes an increase in intestinal per-
meability that allows bacteria to transmigrate from the
intestinal lumen into the circulation (metabolic endotox-
emia), resulting in activation of an inflammatory re-
sponse. This endotoxin elicited inflammation spills over
into the male reproductive tract where it increases leu-
kocytes production of ROS, leading to sperm DNA oxi-
dative attack and a decline in sperm DNA integrity.
Zonulin, a protein dynamically produced by the intes-
tinal epithelium and liver that reversibly regulates intes-
tinal permeability by modulating intercellular tight
junctions and is generally regarded as a useful
non-invasive surrogate marker of intestinal permeability.
In the obese state there is an increase in the basal pro-
duction of zonulin and a resultant decrease in expres-
sion of two epithelial tight junction proteins; occluding
and zonula occludens-1 [37] that then enables bacteria
to translocate between the intestinal lumen and the
bloodstream [38], challenging the immune system to
[13, 22, 23].
Although the mechanism for the increase in circulat-
ing zonulin in obesity is not fully eluded, it is proposed
that inflammatory cytokines such as TNFα, and IL-6
produced by adipose tissue may trigger zonulin release,
further increasing intestinal permeability, allowing more
LPS into circulation. This process highlights the positive
feedback loop relationship between obesity, intestinal
permeability and metabolic endotoxemia [39, 40]. Radd
et al. [41] have recently reviewed the effect of obesity on
sperm parameters, although some discrepancies were
noted, overall these studies indicated that overweight
and obesity in male were associated with an increased
percentage of sperm with DNA fragmentation and ab-
normal mitochondrial membrane potential. In agree-
ment with previous studies in obese men, our study
confirmed that serum zonulin was positively associated
with both obesity (R = 0.331, p = 0.045) [39] and meta-
bolic endotoxemia (R = 0.0374, p = 0.025) [40, 42]. How-
ever, no direct significant relationship was observed
between intestinal permeability (zonulin) and any
marker of sperm quality. However, this lack of signifi-
cance does not exclude intestinal permeability as cause
of reproductive impairment, particular given that serum
zonulin was correlated with endotoxemia and endotoxe-
mia with sperm oxidative DNA damage. Furthermore,
the trans-mucosal passage of gut bacteria occurs by two
pathways [13, 38]. An inter-cellular passage of bacteria
through tight junctions between epithelial cells regulatedby zonulin and the trans-cellular passage of LPS frag-
ments taken up by bile acid micelles and carried across
the intestinal cell membrane independent of zonulin/
ZO action [37]. As LBP measures the net impact of inter
and trans-cellular gut bacterial transmigration, we now
believe that this may explain why we did not see any dir-
ect correlations between zonulin and sperm quality pa-
rameters, yet did between LBP (average of days
endotoxin exposure) and sperm quality. Furthermore,
plasma zonulin undergoes dynamic changes in plasma
levels during the day in response to everyday triggers
such as psychological stress [43] and food [44], poten-
tially confounding direct associations between this rap-
idly fluctuating variable and sperm production with
much longer time lines.
This study is the first to report positive association be-
tween sperm DNA fragmentation with increased endo-
toxin exposure (R = 0.461, p = 0.022) even after
adjustment for age, smoking status and measures of adi-
posity, thereby confirming our hypothesis that the pres-
ence of endotoxin in systemic circulation can potentially
effect sperm quality. Furthermore, there was a significant
positive correlation between endotoxemia and sperm
DNA oxidative damage, plus markers of adiposity and 8
OHdG levels [5]. We interpret these findings as suggest-
ing that obesity is associated with endotoxin initiated in-
flammation and the production of ROS by activated
leukocytes that then oxidatively damage sperm DNA in-
tegrity. Previous work from our group has shown that
low-dose endotoxin administration in healthy men pro-
duces an increase in serum inflammatory cytokines such
as interleukin-6 (IL-6) and tumour necrosis factor-α
(TNF-α), both known to activate leukocyte ROS produc-
tion [16, 45]. Sperm DNA fragmentation is generally ac-
cepted to be related to either ROS damage, apoptosis or
physiological “nicks” generated during DNA packaging/
proamination. We propose that endotoxin exposure may
impair sperm DNA integrity via two mechanisms. Firstly,
an indirect mechanism mediated by activation of male re-
productive tract leukocytes releasing ROS (oxidative
stress). Secondly, a direct mechanism by which LPS may
bind to sperm TLR4 receptors and initiate apoptosis, as
has been shown in vitro in human and murine sperm [38].
As we did not directly measure apoptosis (annexin V or
similar markers) this second apoptotic mechanism of
sperm DNA damage is still theoretical only.
Pilatz et al. [46] showed that systemic inflammation
related to obesity (increase CRP and IL-6) did not trans-
late into an increase in seminal plasma cytokines, or an
increase in seminal plasma elastase, a result also in
agreement with our own findings. This suggest that
obesity related systemic inflammation may not reach the
male reproductive tract, or that LPS initiated localised
inflammation in the epididymis and testis may not
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or elastase, yet still mediate damage to sperm by initiat-
ing localised oxidative stress.
Our results suggest that in the context of obesity re-
lated oxidative DNA damage, a potential alternative ap-
proach to the traditional antioxidant approach may be to
administer therapies that fortify intestinal barrier func-
tion, reducing subsequent metabolic endotoxemia and
inflammation and its associated sperm oxidative damage.
One potential approach would be the use of probiotics
which have been reported to improve intestinal barrier
function, reduce metabolic endotoxemia and inflamma-
tion [47]. Several animal studies [48] and one recent hu-
man RCT [49] have reported that probiotics can indeed
boost sperm quality and testosterone levels. We have
postulated that this beneficial effect is mediated by re-
duction in metabolic endotoxemia [50].
We acknowledge several potential weaknesses in our
study. Firstly, western style diets, excessive alcohol in-
take and smoking are all known to increase systemic in-
flammation [26]. While this study controlled for the 3
men who smoked [51] and excluded men consuming ex-
cessive alcohol, it failed to control for diet. Future stud-
ies should control for the influence of inflammatory
dietary patterns known to exacerbate metabolic endo-
toxaemia such as high fat meals [11]. Secondly, this is
only a pilot study of 37 men. The recruitment of a larger
sample size is likely to produce more statistically rigor-
ous results. Thirdly, while recent meta-analysis show re-
lationships between BMI and DNA fragmentation [44,
52], other studies report conflicting results (reviewed in
[53]), which the authors report may be due to the vari-
ability in study populations (fertile/ subfertile/ general
population), samples size and the heterogeneity of the
sperm DNA integrity assays used (TUNEL assay, sperm
chromatin structure assay (SCSA), flow cytometry,
comet assay method). In this study the Halosperm G2
method was used to assess DNA fragmentation and a
number of steps were taken to ensure the reproducibility
and accuracy of this analysis. These included earlier cali-
bration against the TUNEL method of analysis, sample
analysis within 2 h of receipt, reduction in inter-assay
variability by having a single technician (author 2) per-
form all the analysis and the use of a clinical pathology
accredited laboratory. Previous studies within our la-
boratory have shown very good correlation between
TUNEL and Halosperm methods of assessing sperm
DNA integrity (R2 = 0.872, p < 0.001), plus minimal
inter-observer variability, especially for the the Halos-
perm test. A recent review has also concluded that
Halosperm test is a valid assessment of both sperm
DNA integrity and male fertility potential [54].
Fourthly, there is presently significant uncertainty re-
garding the impact of sperm DNA fragmentation onboth natural and ART assisted fertility. Some of this may
be related to differences in tests performed, the process-
ing of sperm before testing (assessment of neat semen
or swim-up processed samples) and the fact that tests of
sperm DNA integrity are destructive and as such we can
never directly analyse a correlation between the fertilis-
ing sperms DNA integrity and pregnancy outcome.
Finally, we acknowledge that our observational cohort
was recruited from a reproductive clinic, and while we
excluded men with obvious primary testicular failure, it
is possible that the semen parameters and hormone
levels detected in this study may not fully represent
those of the general population. Additionally, differences
in the genetic backgrounds of various ethnic populations
and epigenetics should also be considered [55]. It is also
possible that hormone levels were influenced by sleep
disturbances [56] or endocrine disruptors [57] which
was not assessed in our study. It is also possible that par-
ticipant endotoxin levels were influenced psychologically
as a result of the stresses of undergoing fertility treat-
ment [58, 59].
Conclusions
The results of this study suggest for the first time a link
between obesity induced by ME, increasing intestinal
permeability and endotoxin levels, and oxidative medi-
ated sperm DNA damage. Although we were unable to
detect a direct relationship was between intestinal per-
meability (plasma zonulin) and any marker of sperm
quality, we believe this reflects the fact that zonulin mir-
rors only changes in para-cellular intestinal permeability,
not trans-cellular passage of gut endotoxin mediated by
fat and bile micelles. These results are important as they
suggest that new therapies directed at enhancing intes-
tinal barrier function may be able to reduce obesity re-
lated inflammation oxidative stress, thereby boosting
sperm quality.
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